Data / Form D filings / ANTERIOS INC
ANTERIOS INC: Form D filings
ANTERIOS INC, a biotechnology company in New York, NY, filed 6 Form D notices with the SEC between 2009 and 2013. The latest, on April 9, 2013, reports $4.7 million sold of a $6.6 million offering to 12 investors.
Find out what ANTERIOS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 142 West 57th Street, Suite 4A, New York, NY, 10019
- Phone
- (212) 303-1683
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1390085
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 9, 2013 | New notice | $6,612,829 | $4,744,055 | $1,868,774 | 12 | Mar 25, 2013 | sec.gov |
| Jul 22, 2011 | New notice | $3,500,001 | $3,035,007 | $464,994 | 10 | Jul 8, 2011 | sec.gov |
| Dec 29, 2010 | New notice | $1,999,992 | $1,999,992 | $0 | 1 | Dec 16, 2010 | sec.gov |
| Sep 3, 2010 | New notice | $2,500,000 | $750,000 | $1,750,000 | 6 | Aug 19, 2010 | sec.gov |
| Feb 18, 2010 | New notice | $1,500,000 | $1,500,000 | $0 | 1 | Feb 3, 2010 | sec.gov |
| Oct 21, 2009 | New notice | $10,000,000 | $5,165,495 | $4,834,505 | 15 | Oct 6, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jon Edelson | Executive Officer, Director | |
| Carter Meyer | Director | |
| Geoffrey Smith | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Apr 8, 2013 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ANTERIOS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.